IL-1β suppresses prolonged Akt activation and expression of E2F-1 and cyclin A in breast cancer cells

Journal of Immunology

Volumn 172, Issue 12, 2004, Pages 7272-7281

  Shen, Wen Hong ^a   Jackson, Steve T ^a   Broussard, Suzanne R ^a   McCusker, Robert H ^a   Strle, Klemen ^a   Freund, Gregory G ^b   Johnson, Rodney W ^a   Dantzer, Robert ^c   Kelley, Keith W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

^c INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; CYCLIN A; CYCLIN DEPENDENT KINASE 2; DNA; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RAPAMYCIN; RETINOBLASTOMA PROTEIN; S6 KINASE; SOMATOMEDIN C; TRANSCRIPTION FACTOR E2F1; AKT1 PROTEIN, HUMAN; CDK2 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; INTERLEUKIN 1; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL CYCLE; CELL STRAIN MCF 7; DNA SYNTHESIS; ENZYME ASSAY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; BIOSYNTHESIS; BREAST TUMOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; INTERPHASE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; TUMOR CELL LINE;

BREAST NEOPLASMS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERLEUKIN-1; INTERPHASE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR CROSS-TALK; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 2942556904     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.12.7272     Document Type: Article

References (58)

1. 1 cyclins and cell cycle progression. Proc. Assoc. Am. Physicians 107:181.
2. 1 cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 12:676.
3. Baserga, R., P. Porcu, M. Rubini, and C. Sell. 1993. Cell cycle control by the IGF-1 receptor and its ligands. Adv. Exp. Med. Biol. 343:105.
4. Vivo, C., F. Levy, Y. Pilatte, J. Fleury-Feith, P. Chretien, I. Monnet, L. Kheuang, and M. C. Jaurand. 2001. Control of cell cycle progression in human mesothelioma cells treated with γ interferon. Oncogene 20:1085.
5. Elkordy, M., M. Crump, J. J. Vredenburgh, W. P. Petros, A. Hussein, P. Rubin, M. Ross, C, Gilbert, C. Modlin, B. Meisenberg, et al. 1997. A phase I trial of recombinant human interleukin-1β (OCT-43) following high-dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant. 19:315.
6. Apte, R. N., and E. Voronov. 2002. Interleukin-1-α major pleiotropic cytokine in tumor-host interactions. Semin. Cancer Biol. 12:277.
7. Shen, W. H., J. H. Zhou, S. R. Broussard, G. G. Freund, R. Dantzer, and K. W. Kelley. 2002. Proinflammatory cytokines block growth of breast cancer cells by impairing signals from a growth factor receptor. Cancer Res. 62:4746.
8. Kohm, A. P., A. Mozaffarian, and V. M. Sanders. 2002. B cell receptor- and β2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J. Immunol. 168:6314.
9. Maile, L. A., and D. R. Clemmons. 2003. Integrin-associated protein binding domain of thrombospondin-1 enhances insulin-like growth factor-I receptor signaling in vascular smooth muscle cells. Circ. Res. 93:925.
10. Yam, C. H., T. K. Fung, and R. Y. Poon. 2002. Cyclin A in cell cycle control and cancer. Cell Mol. Life Sci. 59:1317.
11. Bukholm, I. R., G. Bukholm, and J. M. Nesland. 2001. Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas. Int. J. Cancer 93:283.
12. Bortner, D. M., and M. P. Rosenberg. 1995. Overexpression of cyclin A in the mammary glands of transgenic mice results in the induction of nuclear abnormalities and increased apoptosis. Cell Growth Differ. 6:1579.
13. Rosenberg, A. R., F. Zindy, F. Le Deist, H. Mouly, P. Metezeau, C. Brechot, and E. Lamas. 1995. Overexpression of human cyclin A advances entry into S phase. Oncogene 10:1501.
14. Zhao, J. J., O. V. Gjoerup, R. R. Subramanian, Y. Cheng, W. Chen, T. M. Roberts, and W. C. Hahn. 2003. Human mammary epithelial cell transformation through the activation of phosphatidylinositol 3-kinase. Cancer Cells 3:483.
15. Klippel, A., M. A. Escobedo, M. S. Wachowicz, G. Apell, T. W. Brown, M. A. Giedlin, W. M. Kavanaugh, and L. T. Williams. 1998. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol. Cell. Biol. 18:5699.
16. Brennan, P., J. W. Babbage, B. M. Burgering, B. Groner, K. Reif, and D. A. Cantrell. 1997. Phosphatidylinositol 3-kinase couples the interleukin-2 receptor to the cell cycle regulator E2F. Immunity 7:679.
17. Shen, W. H., Y. Yin, S. R. Broussard, R. H. McCusker, G. G. Freund, R. Dantzer, and K. W. Kelley. 2004. TNFα inhibits cyclin A expression and RB hyperphosphorylation triggered by IGF-I induction of new E2F-1 synthesis. J. Biol. Chem. 279:7438.
18. Hamelers, I. H., R. F. van Schaik, J. Sipkema, J. S. Sussenbach, and P. H. Steenbergh. 2002. Insulin-like growth factor I triggers nuclear accumulation of cyclin D1 in MCF-7S breast cancer cells. J. Biol. Chem. 277:47645.
19. KIP1 inhibitor characterize early development of promyeloid cells into macrophages. Mol. Cell. Biol. 19:6229.
20. You, H., H. Zheng, S. A. Murray, Q. Yu, T. Uchida, D. Fan, and Z. X. Xiao. 2002. IGF-1 induces Pin1 expression in promoting cell cycle S-phase entry. J. Cell. Biochem. 84:211.
21. Favoni, R. E., and A. de Cupis. 2000. The role of polypeptide growth factors in human carcinomas: new targets for a novel pharmacological approach. Pharmacol. Rev. 52:179.
22. Statistical Analysis System. 2001. SAS for Windows ver. 8.2. SAS Institute, Cary, NC.
23. Aaronson, S. A. 1991. Growth factors and cancer. Science 254:1146.
24. Varma, H., and S. E. Conrad. 2002. Antiestrogen ICI 182,780 decreases proliferation of insulin-like growth factor I (IGF-I)-treated MCF-7 cells without inhibiting IGF-1 signaling. Cancer Res. 62:3985.
25. Chang, F., J. T. Lee, P. M. Navolanic, L. S. Steelman, J. G. Shelton, W. L. Blalock, R. A. Franklin, and J. A. McCubrey. 2003. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590.
26. Mita, M. M., A. Mita, and E. K. Rowinsky. 2003. Mammalian target of rapamycin: a new molecular target for breast cancer. Clin. Breast Cancer 4:126.
27. Wilkinson, M. G., and J. B. Millar. 2000. Control of the eukaryotic cell cycle by MAP kinase signaling pathways. FASEB J. 14:2147.
28. Blume-Jensen, P., and T. Hunter. 2001. Oncogenic kinase signalling. Nature 411:355.
29. s6k. FEBS Lett. 410:78.
30. Vlahos, C. J., W. F. Matter, K. Y. Hui, and R. F. Brown. 1994. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:5241.
31. 1-arresting rapamycin-receptor complex. Nature 369:756.
32. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
33. Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, and Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.
34. Minshall, C., S. Arkins, R. Dantzer, G. G. Freund, and K. W. Kelley. 1999. Phosphatidylinositol 3′-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors. J. Immunol. 162:4542.
35. Jackson, J. G., M. F. White, and D. Yee. 1998. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J. Biol. Chem. 273:9994.
36. Dufourny, B., J. Alblas, H. A. van Teeffelen, F. M. van Schaik, B. van der Burg, P. H. Steenbergh, and J. S. Sussenbach. 1997. Mitogenic signaling of insulin-like growth factor I in MCF-7 human breast cancer cells requires phosphatidylinositol 3-kinase and is independent of mitogen-activated protein kinase. J. Biol. Chem. 272:31163.
37. Schulze, A., K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Durr, and B. Henglein. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92:11264.
38. Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245.
39. Orlovsky, K., L. Theodor, H. Malovani, Y. Chowers, and U. Nir. 2002. γ interferon down-regulates Fer and induces its association with inactive Stat3 in colon carcinoma cells. Oncogene 21:4997.
40. Buolamwini, J. K. 2000. Cell cycle molecular targets in novel anticancer drug discovery. Curr. Pharm. Des. 6:379.
41. Frouin, I., A. Montecucco, G. Biamonti, U. Hubscher, S. Spadari, and G. Maga. 2002. Cell cycle-dependent dynamic association of cyclin/Cdk complexes with human DNA replication proteins. EMBO J. 21:2485.
42. Gartel, A. L., M. S. Serfas, and A. L. Tyner. 1996. p21-negative regulator of the cell cycle. Proc. Soc. Exp. Biol. Med. 213:138.
43. WAF1/Cip1 functions as a suppressor of malignant skin tumor formation and a determinant of keratinocyte stem-cell potential. Proc. Natl. Acad. Sci. USA 96:9089.
44. WAF1/CIP1 gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity. Biochem. Biophys. Res. Commun. 233:329.
45. 2 phase growth arrest of A375S2 human melanoma cells. J. Biol. Chem. 276:6797.
46. mapk are required for fibroblast proliferation. Proc. Natl. Acad. Sci. USA 90:8319.
47. MAPK pathway. J. Biol. Chem. 271:20608.
48. Nelsen, C. J., D. G. Rickheim, M. M. Tucker, L. K. Hansen, and J. H. Albrecht. 2003. Evidence that cyclin D1 mediates both growth and proliferation downstream of TOR in hepatocytes. J. Biol. Chem. 278:3656.
49. Rosenwald, I. B., R. Kaspar, D. Rousseau, L. Gehrke, P. Leboulch, J. J. Chen, E. V. Schmidt, N. Sonenberg, and I. M. London. 1995. Eukaryotic translation initiation factor 4E regulates expression of cyclin D1 at transcriptional and posttranscriptional levels. J. Biol. Chem. 270:21176.
50. 1 to S transition is mediated by effects on cyclin D1 mRNA and protein stability. J. Biol. Chem. 273:14424.
51. Scott, P. H., G. J. Brunn, A. D. Kohn, R. A. Roth, and J. C. Lawrence, Jr. 1998. Evidence of insulin-stimulated phosphorylation and activation of the mammalian target of rapamycin mediated by a protein kinase B signaling pathway. Proc. Natl. Acad. Sci. USA 95:7772.
52. Fang, Y., M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen. 2001. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942.
53. Chen, J. 2004. Novel regulatory mechanisms of mTOR signaling. Curr. Top. Microbiol. Immunol. 279:245.
54. Abraham, R. T. 1996. Phosphatidylinositol 3-kinase related kinases. Curr. Opin. Immunol. 8:412.
55. 1. Curr. Biol. 9:512.
56. 1 events and regulation of cell proliferation. Science 246:603.
57. Jones, S. M., and A. Kazlauskas. 2001. Growth-factor-dependent mitogenesis requires two distinct phases of signalling. Nat. Cell Biol. 3:165.
58. Planas-Silva, M. D., and R. A. Weinberg. 1997. The restriction point and control of cell proliferation. Curr. Opin. Cell Biol. 9:768.